4//SEC Filing
KENNEY CHRISTOPHER JOHN 4
Accession 0000950170-24-030239
CIK 0001582313other
Filed
Mar 11, 8:00 PM ET
Accepted
Mar 12, 6:38 PM ET
Size
14.7 KB
Accession
0000950170-24-030239
Insider Transaction Report
Form 4
KENNEY CHRISTOPHER JOHN
Chief Medical Officer
Transactions
- Award
Stock Option (Right to Buy)
2024-03-11+100,000→ 100,000 totalExercise: $44.37Exp: 2034-03-10→ Common Shares (100,000 underlying)
Footnotes (1)
- [F1]Vesting 25% on January 1, 2025, and 75% vesting thereafter over the course of the next 3 years, in equal amounts, on the last day of each month.
Issuer
Xenon Pharmaceuticals Inc.
CIK 0001582313
Entity typeother
Related Parties
1- filerCIK 0001880129
Filing Metadata
- Form type
- 4
- Filed
- Mar 11, 8:00 PM ET
- Accepted
- Mar 12, 6:38 PM ET
- Size
- 14.7 KB